Athlone, Ireland

Kristopher Perkin

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 6.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Athlone, IE (2018 - 2021)
  • Dublin, IE (2023 - 2024)

Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Mind of Kristopher Perkin

Introduction: Kristopher Perkin is a prominent inventor based in Athlone, Ireland, known for his significant contributions to the pharmaceutical field. With a portfolio of seven patents to his name, he has demonstrated a commitment to innovation and advancing medical technology, particularly in the area of drug delivery systems.

Latest Patents: Among Kristopher Perkin’s most notable recent inventions are his immediate release multilayer tablets designed for the oral delivery of olanzapine and samidorphan. These innovative tablets have been crafted to effectively treat various disorders, broadening the therapeutic options available to healthcare providers. The detailed patent descriptions reveal methods of utilizing these tablets, alongside kits that incorporate them, showcasing a thoughtful approach to patient care.

Career Highlights: Kristopher is currently affiliated with Alkermes Pharma Ireland Limited, a company renowned for its focus on innovative therapies for CNS disorders. His work there emphasizes the importance of developing practical solutions to complex medical challenges, further solidifying his status as a leading inventor in the pharmaceutical industry.

Collaborations: Throughout his career, Kristopher has collaborated with talented individuals such as David Manser and Philip Cresswell. These partnerships not only enhance the creativity and effectiveness of the innovations they produce but also foster a collaborative environment conducive to advancing medical science.

Conclusion: Kristopher Perkin's contributions to the field of pharmaceuticals reflect a deep understanding of both scientific principles and patient needs. His seven patents are a testament to his inventive spirit and dedication to improving health outcomes. As he continues to innovate at Alkermes Pharma Ireland Limited, the future looks promising for new developments in oral drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…